Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsOPHTHALMICStandard

PHOSPHOLINE IODIDE

ECHOTHIOPHATE IODIDE

Standard Dose
0.125%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview PHOSPHOLINE IODIDE is listed in Drugs@FDA under application 011963 (NDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient ECHOTHIOPHATE IODIDE Form and strength FOR SOLUTION;OPHTHALMIC - 0.125% Sponsor FERA PHARMS LLC Submission history Latest submission status date: 2021-10-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview PHOSPHOLINE IODIDE is listed in Drugs@FDA under application 011963 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ECHOTHIOPHATE IODIDE Form and strength FOR SOLUTION;OPHTHALMIC - 0.125% Sponsor FERA PHARMS LLC Submission history Latest submission status date: 2021-10-28 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.